The development and adoption of nonproprietary, established, and proprietary names for pharmaceuticals

Drug Information Journal

Volumn 31, Issue 3, 1997, Pages 621-634

  Boring, Dan ^a,b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CDER Labeling Nomenclature Committee   (United States)

Author keywords

Established names; Nonproprietary names; Proprietary names; Trademark

Indexed keywords

ALPRAZOLAM; ANTIASTHMATIC AGENT; ANTIHISTAMINIC AGENT; AZMATROL; DESOXIMETASONE; DIFLORASONE DIACETATE; DIPHENHYDRAMINE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; NON PRESCRIPTION DRUG; OCTREOTIDE; PENICILLIN V POTASSIUM; UNCLASSIFIED DRUG;

ARTICLE; DRUG CLASSIFICATION; DRUG INDUSTRY; DRUG LABELING; FOOD AND DRUG ADMINISTRATION; PATENT; PRIORITY JOURNAL; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 0030750150     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159703100301     Document Type: Article

References (12)

1. The United States Pharmacopeia. Rockville, MD: The United States Pharmacopeial Convention, Inc., 1995;23:Preface.
2. Kopp-Kubel S. Drug Nomenclature. In: The Practice of Medicinal Chemistry. Orlando, FL: Academic Press Ltd.; 1996:863-877.
3. The USP Dictionary of USAN and International Drug Names. Rockville, MD: The United States Pharmacopeial Convention, Inc., 1997; Preface and Appendices I and II.
4. The United States Adopted Name Council Handbook. Fourth ed. Chicago, IL: American Medical Association; 195.
5. General Notices to the United States Pharmacopeia. 1995;23(2).
6. DiDomizio G, president, Gemini Trademark Service. Personal communication. 1996.
7. Detorre JL, president, Brand Institute, Inc. Personal communication. 1996.
8. USPTO. Basic Facts About Registering a Trademark. Arlington, VA: United States Patent and Trademark Office; 1997.
9. Boring DL. The CDER Labeling and Nomenclature Committee: Structure, Function, and Process. Drug Inf J. 1997;31:7-11.
10. Boring DL, Homonnay-Weikel AM, Cohen M, Di-Domizio G. Avoiding Trademark Trouble at FDA. Pharma Exec. 1996;16:80-88.
11. Boring DL, Doninger C. The Need for Balancing the Regulation of Pharmaceutical Trademarks Between the Food and Drug Administration and the Patent and Trademark Office. Food Drug Law J. 1997;52:109-116.
12. Lear TS, Briceland L, Stein D. Factors Related to Errors in Medication Prescribing. JAMA. 1997;277: 312-317.